RxDoctor Payments Data

Darren Smucker, MD

Family Medicine · Tallmadge, OHNPI 1114422953

Payments from drug & device makers

$713in general payments, 2019–2025

Across 42 payments — averaging $16.98 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$156
  • AstraZeneca$73
  • E.r. Squibb & Sons, L.L.C.$55
  • Bayer$49
  • Sumitomo Pharma America, Inc.$48
  • GSK$46
  • plus $286 from 13 others

What the payments were for

  • Food & beverage$713100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$713 in reported general payments places this provider in the 55th percentile of 3,983 family medicine providers in Ohio.

See all family medicine providers in Ohio

Medicare billing

Part B allowed, 2024
$105,399
Medicare patients
288
Services billed
1,848

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
OzempicSemaglutide105$106,673
JardianceEmpagliflozin87$104,353
EliquisApixaban58$83,711
TrulicityDulaglutide34$36,858
XareltoRivaroxaban28$35,445
Repatha SureclickEvolocumab19$23,421
FarxigaDapagliflozin Propanediol17$23,082
Trelegy ElliptaFluticasone/Umeclidin/Vilanter13$17,781
Semglee (Yfgn) PenInsulin Glargine-Yfgn18$10,845
Breo ElliptaFluticasone/Vilanterol13$6,574
BrilintaTicagrelor13$5,441
Lantus SolostarInsulin Glargine,hum.Rec.Anlog46$4,919
Atorvastatin Calcium616$4,516
Budesonide-Formoterol FumarateBudesonide/Formoterol Fumarate22$4,290
Rosuvastatin Calcium442$3,888

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Novo NordiskOzempic$45$106,673105 claims
Boehringer IngelheimJardiance$18$104,35387 claims
Lilly USA, LLCTrulicity$31$36,85834 claims
AstraZenecaFarxiga, Brilinta, Symbicort$73$31,16942 claims
GSKTrelegy Ellipta, Breo Ellipta$46$24,35526 claims
AbbVieSynthroid$156$1,62847 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 55th percentile of 3,983 family medicine providers in Ohio.

Other family medicine in Tallmadge

See the full list for Ohio

Where these figures come from

Is this you, or does something look wrong? →